Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EORTC CLTF 2021 | Multimarker approach to CTC analysis in CTCL

Maarten Vermeer • 15 Oct 2021
EORTC CLTF 2021
Cutaneous T-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases

Maarten Vermeer, MD, PhD, Leiden University Medical Center, Leiden, Netherlands, gives an overview of the multimarker approach to biomarker research and its role in the quantification of circulating tumor cells (CTCs) for diagnosis and treatment-response analysis in cutaneous T-cell lymphoma (CTCL). This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

More from Maarten Vermeer

1:01
Measuring CTCs in CTCL
Maarten Vermeer • 15 Oct 2021
1:42
The benefits of improving tumor cell quantification in CTCL
Maarten Vermeer • 15 Oct 2021
1:10
Unmet needs for late-stage CTCL
Maarten Vermeer • 15 Oct 2021
1:04
Unmet needs in early-stage mycosis fungoides
Maarten Vermeer • 15 Oct 2021

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals